News / Press Releases - March 19, 2024
on ENVI reports on the EU Pharmaceutical Package Today, 19 March 2024, the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) adopted the two reports on the so-called EU Pharmaceutical Package, namely the Directive on Medicinal products for human use and… read more
News / Press Releases - March 15, 2024
Negotiators from the European Council and the European Parliament reached a provisional agreement on the EHDS in the early morning of Friday, 15 March 2024. This means that there is just enough time for formal adoption before the new political mandate following the European elections… read more
Press Releases - March 6, 2024
EUCOPE as part of a coalition of 35 large health stakeholder organisations representing patients, health professionals, researchers and industrial actors in the healthcare ecosystem at both European Union (EU) and Member State level, is expressing its shared concerns about the latest negotiations on the proposed… read more
News - March 4, 2024
EUCOPE’s Position Determined to make this Europe’s ‘‘Digital Decade’’, the European Commission’s key priority with the proposal of the European Health Data Space (EHDS) is to promote the digital transformation of Europe’s health sector and improve EU healthcare systems. EUCOPE continues to support the creation… read more
Member Spotlight / News - February 5, 2024
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
EUCOPE Resources / Events & Meetings - December 18, 2023
On 14 December, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the fourth episode of its #LifeScienceLectures webinar series. The focus of the webinar, titled “Leveraging early advice opportunities in EU HTA” was to discuss how best to navigate early advice opportunities with the new… read more
News - December 11, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In November, we spoke with Kenneth Saké – Vice President of International Medical Affairs, Blueprint Medicines. Tell us about… read more
News / Press Releases - December 4, 2023
4 December 2023, Brussels – EUCOPE, as part of a large multi-stakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 36 European patient organisations, medical associations, health research infrastructures and health industry associations, have issued a joint statement to alarm bells… read more
News / Press Releases - October 26, 2023
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 9 new members at its quarterly Members Meeting on October 18th, 2023 following Board approval. The new members joining the EUCOPE network are Angelini Pharma, Dipharma, Italfarmaco, Labcorp, Metriopharm AG, Otsuka, Pharming Group, Pharvaris… read more
News - October 24, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Margarida Duarte, Senior Vice President, Head of International, Deciphera Pharmaceuticals. Margarida Duarte is Senior… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information